Development of Fluridil, a Topical Suppressor of the Androgen Receptor in Androgenetic Alopecia

July 2003 in “ Drug Development Research ”

Allen L. Seligson, Brian K. Campion, Jason W. Brown, Ron Terry, Renata Kucerova, Martina Bienová Ph.D, Marian Hajduch, Milos Sovak

fluridil androgen receptor androgenetic alopecia hair growth topical delivery dermal hair papilla AGA

TLDR Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

The paper discusses the development of fluridil, a topical suppressor of the androgen receptor for the treatment of androgenetic alopecia (AGA). Fluridil was found to be effective in promoting hair growth in a 12-month clinical study of male AGA patients, with no adverse side effects reported. The compound was designed to achieve rapid degradation into innocuous components, no systemic absorption from the scalp, and topical delivery to the dermal hair papilla. Fluridil was shown to be well-tolerated and safe in mice, with little potential for human hazard at the intended topical dose. The study suggests that fluridil may be a promising treatment for AGA.

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

13 / 13 results

research Towards a Molecular Understanding of Hair Loss and Its Treatment

236 citations, July 2001 in “Trends in Molecular Medicine”

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

research Testosterone Levels in Healthy Men and the Relation to Behavioral and Physical Characteristics: Facts and Constructs

229 citations, March 2001 in “European journal of endocrinology”

Testosterone levels influence male behaviors and physical traits, but this relationship is complex and influenced by both internal and external factors.

research Treatments for Androgenetic Alopecia and Alopecia Areata

72 citations, January 2001 in “Drugs”

Minoxidil and finasteride treat hair loss; more research needed for other options.

research Lack of Effect of Topical Finasteride Suggests an Endocrine Role for Dihydrotestosterone

12 citations, August 2000 in “Fertility and Sterility”

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

research Androgen Receptor Antagonists Structure-Activity Relationships

204 citations, February 2000 in “Current Medicinal Chemistry”

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

research Treatment of Hair Loss

370 citations, September 1999 in “The New England Journal of Medicine”

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

research Finasteride in the Treatment of Men with Androgenetic Alopecia

581 citations, October 1998 in “Journal of The American Academy of Dermatology”

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

Evaluation of RU58841 as an Anti-Androgen in Prostate PC3 Cells and a Topical Anti-Alopecia Agent in the Bald Scalp of Stumptailed Macaques

research Evaluation of RU58841 as an Anti-Androgen in Prostate PC3 Cells and a Topical Anti-Alopecia Agent in the Bald Scalp of Stumptailed Macaques

18 citations, January 1998 in “Endocrine”

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

research A Controlled Study of the Effects of RU58841, a Non-Steroidal Antiandrogen, on Human Hair Production by Balding Scalp Grafts Maintained on Testosterone-Conditioned Nude Mice

9 citations, November 1997 in “British Journal of Dermatology”

Inhibition of Hair Growth by Testosterone in the Presence of Dermal Papilla Cells from the Frontal Bald Scalp of the Postpubertal Stumptailed Macaque

research Inhibition of Hair Growth by Testosterone in the Presence of Dermal Papilla Cells from the Frontal Bald Scalp of the Postpubertal Stumptailed Macaque

33 citations, January 1997 in “Endocrinology”

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

research Topical Finasteride in the Treatment of Androgenic Alopecia: Preliminary Evaluations After a 16-Month Therapy Course

30 citations, January 1997 in “Journal of Dermatological Treatment”

Topical finasteride helps regrow hair and reduce balding without side effects.

Preliminary Pharmacokinetics and Metabolism of Novel Non-Steroidal Antiandrogens in the Rat: Relation of Their Systemic Activity to the Formation of a Common Metabolite

research Preliminary Pharmacokinetics and Metabolism of Novel Non-Steroidal Antiandrogens in the Rat: Relation of Their Systemic Activity to the Formation of a Common Metabolite

16 citations, October 1994 in “The Journal of Steroid Biochemistry and Molecular Biology”

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

research RU 58841, A New Specific Topical Antiandrogen: A Candidate of Choice for the Treatment of Acne, Androgenetic Alopecia, and Hirsutism

49 citations, January 1994 in “The Journal of Steroid Biochemistry and Molecular Biology”

RU 58841 may treat acne, hair loss, and excessive hair growth.

Related Research

1 / 1 results

Activity of 17β-(N-Alkyl/Arylformamido) and 17β-[(N-Alkyl/Aryl) Alkyl/Arylamido]-4-Methyl-4-Aza-5α-Androstan-3-Ones as 5α-Reductase Inhibitors in the Hamster Flank Organ and Ear

research Activity of 17β-(N-Alkyl/Arylformamido) and 17β-[(N-Alkyl/Aryl) Alkyl/Arylamido]-4-Methyl-4-Aza-5α-Androstan-3-Ones as 5α-Reductase Inhibitors in the Hamster Flank Organ and Ear

10 citations, August 1998 in “Journal of Investigative Dermatology”

The compounds tested could potentially treat hair loss and alopecia.